相关实验视频

Updated: Jun 3, 2025

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

tRF-33/IGF1轴对HER2-阴性乳腺癌中线粒体稳态失调

Yuming Lou¹, Bifei Fu¹, Lutong Liu²

¹Department of Breast and Thyroid Surgery, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, People's Republic of China.

American journal of physiology. Cell physiology

|January 10, 2025

概括

转移RNA衍生小RNAs (tsRNAs) 促进乳腺癌 (BC) 的进展. 这项研究确定了一种特定的tsRNA,tRF-33,它准IGF1,影响线粒体功能并推动HER2-负BC生长.

科学领域:

分子生物学分子生物学
遗传学是一个遗传学.
在瘤学瘤学.

背景情况:

转移RNA衍生小RNAs (tsRNAs) 是一种涉及各种癌症的非编码RNAs类.
在瘤发生过程中注意到tsRNAs的失调,但它们在乳腺癌 (BC) 中的具体作用尚未完全阐明.
HER2-阴性BC代表了一个重要的亚型,需要新的治疗点.

研究的目的:

为了研究TSRNAs在HER2阴性乳腺癌中的功能.
为了确定参与BC进展的特定tsRNAs.
为了阐明基底的分子机制tsRNA介导的BC开发.

主要方法:

在HER2-阴性BC组织和细胞系中对tsRNAs的差异表达分析.
试验室试验评估tRF-33对BC细胞增殖,迁移和侵入性的影响.
在体内研究以评估瘤进展.
涉及基因鉴定和验证的作用研究的机制 (例如,3'-UTR结合试验).

主要成果:

从tRNA-Lys^TTT衍生出的tRF-33-MEF91SS2PMFI0Q (tRF-33) 在HER2-阴性BC中显著上调.
过度表达tRF-33增强了BC细胞的增殖,迁移和侵入性在体外,并在体内促进了瘤的生长.
tRF-33直接与IGF1的3'-UTR结合,导致IGF1mRNA和蛋白质水平降低.
这种tRF-33/IGF1相互作用会破坏线粒体平衡和动态,从而导致BC的进展.

结论:

tRF-33是HER2阴性乳腺癌中一种新型的瘤性tsRNA.
tRF-33/IGF1轴代表了一种新的调节途径,影响BC中的线粒体功能.
向tRF-33或tRF-33/IGF1通路可能为HER2-阴性BC提供潜在的治疗策略.

关键词:

在HER2阴性乳腺癌.IGF1 IGF1 的一个例子.线粒体的恒常状态是线粒体的恒常状态 tRF-33-MEF91SS2PMFI0Q (tRF-33) 的使用情况由tRNA衍生的小RNAs (tsRNAs) 进行检测.

更多相关视频

Assessment of Mitochondrial Health in Cancer-Associated Fibroblasts Isolated from 3D Multicellular Lung Tumor Spheroids

Assessment of Mitochondrial Health in Cancer-Associated Fibroblasts Isolated from 3D Multicellular Lung Tumor Spheroids

Published on: October 21, 2022

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

相关概念视频

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Electron Transport Chain: Complex I and II

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

TGF - β Signaling Pathway

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...

Translocation of Proteins into the Mitochondria

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...